Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle

Hayashi Yoshimura, Keith A. Jones, William J. Perkins, David Oman Warner

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Contraction of airway smooth muscle is regulated by receptor-coupled mechanisms that control the force developed for a given cytosolic calcium concentration (i.e., calcium sensitivity). Halothane antagonizes acetylcholine-induced increases in calcium sensitivity by inhibiting GTP-binding (G)-protein pathways. The authors tested the hypothesis that hexanol, like halothane, inhibits agonist-induced increases in calcium sensitivity in airway smooth muscle by inhibiting G-protein pathways. Methods: Calcium sensitivity was assessed using α-toxin-permeabilized canine tracheal smooth muscle. In selected experiments, regulatory myosin light chain phosphorylation was also determined by Western blotting in the presence and absence of 10 mM hexanol and/or 100 μM acetylcholine. Results: Hexanol (10 mM) and halothane (0.76 mM) attenuated acetylcholine-induced calcium sensitization by decreasing regulatory myosin light chain phosphorylation during receptor stimulation. Hexanol also inhibited increases in calcium sensitivity due to direct stimulation of heterotrimeric G-proteins with tetrafluoroaluminate but not with 3 μM GTPγS, consistent with prior results obtained with halothane. In contrast, in the absence of receptor stimulation, both compounds produced a small increase in calcium sensitivity by a G-protein - mediated increase in regulatory myosin light chain phosphorylation that was not affected by pertussis toxin treatment. Conclusions: The authors noted dual effects of hexanol and halothane. In the presence of muscarinic receptor stimulation, hexanol, like halothane, decreases calcium sensitivity by interfering with heterotrimeric G-protein function. However, in the absence of muscarinic receptor stimulation, hexanol and halothane slightly increase calcium sensitivity by a G-protein-mediated process not sensitive to pertussis toxin. Hexanol may represent a useful experimental tool to study the effect of anesthetics on heterotrimeric G-protein function.

Original languageEnglish (US)
Pages (from-to)871-880
Number of pages10
JournalAnesthesiology
Volume98
Issue number4
DOIs
StatePublished - Apr 1 2003

Fingerprint

Hexanols
Halothane
Smooth Muscle
Calcium
GTP-Binding Proteins
Heterotrimeric GTP-Binding Proteins
Myosin Light Chains
Acetylcholine
Pertussis Toxin
Phosphorylation
Muscarinic Receptors
Anesthetics
Canidae
Western Blotting

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle. / Yoshimura, Hayashi; Jones, Keith A.; Perkins, William J.; Warner, David Oman.

In: Anesthesiology, Vol. 98, No. 4, 01.04.2003, p. 871-880.

Research output: Contribution to journalArticle

Yoshimura, Hayashi ; Jones, Keith A. ; Perkins, William J. ; Warner, David Oman. / Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle. In: Anesthesiology. 2003 ; Vol. 98, No. 4. pp. 871-880.
@article{a4a1bb524879487bb13664e5c6c5b282,
title = "Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle",
abstract = "Background: Contraction of airway smooth muscle is regulated by receptor-coupled mechanisms that control the force developed for a given cytosolic calcium concentration (i.e., calcium sensitivity). Halothane antagonizes acetylcholine-induced increases in calcium sensitivity by inhibiting GTP-binding (G)-protein pathways. The authors tested the hypothesis that hexanol, like halothane, inhibits agonist-induced increases in calcium sensitivity in airway smooth muscle by inhibiting G-protein pathways. Methods: Calcium sensitivity was assessed using α-toxin-permeabilized canine tracheal smooth muscle. In selected experiments, regulatory myosin light chain phosphorylation was also determined by Western blotting in the presence and absence of 10 mM hexanol and/or 100 μM acetylcholine. Results: Hexanol (10 mM) and halothane (0.76 mM) attenuated acetylcholine-induced calcium sensitization by decreasing regulatory myosin light chain phosphorylation during receptor stimulation. Hexanol also inhibited increases in calcium sensitivity due to direct stimulation of heterotrimeric G-proteins with tetrafluoroaluminate but not with 3 μM GTPγS, consistent with prior results obtained with halothane. In contrast, in the absence of receptor stimulation, both compounds produced a small increase in calcium sensitivity by a G-protein - mediated increase in regulatory myosin light chain phosphorylation that was not affected by pertussis toxin treatment. Conclusions: The authors noted dual effects of hexanol and halothane. In the presence of muscarinic receptor stimulation, hexanol, like halothane, decreases calcium sensitivity by interfering with heterotrimeric G-protein function. However, in the absence of muscarinic receptor stimulation, hexanol and halothane slightly increase calcium sensitivity by a G-protein-mediated process not sensitive to pertussis toxin. Hexanol may represent a useful experimental tool to study the effect of anesthetics on heterotrimeric G-protein function.",
author = "Hayashi Yoshimura and Jones, {Keith A.} and Perkins, {William J.} and Warner, {David Oman}",
year = "2003",
month = "4",
day = "1",
doi = "10.1097/00000542-200304000-00013",
language = "English (US)",
volume = "98",
pages = "871--880",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Dual effects of hexanol and halothane on the regulation of calcium sensitivity in airway smooth muscle

AU - Yoshimura, Hayashi

AU - Jones, Keith A.

AU - Perkins, William J.

AU - Warner, David Oman

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Background: Contraction of airway smooth muscle is regulated by receptor-coupled mechanisms that control the force developed for a given cytosolic calcium concentration (i.e., calcium sensitivity). Halothane antagonizes acetylcholine-induced increases in calcium sensitivity by inhibiting GTP-binding (G)-protein pathways. The authors tested the hypothesis that hexanol, like halothane, inhibits agonist-induced increases in calcium sensitivity in airway smooth muscle by inhibiting G-protein pathways. Methods: Calcium sensitivity was assessed using α-toxin-permeabilized canine tracheal smooth muscle. In selected experiments, regulatory myosin light chain phosphorylation was also determined by Western blotting in the presence and absence of 10 mM hexanol and/or 100 μM acetylcholine. Results: Hexanol (10 mM) and halothane (0.76 mM) attenuated acetylcholine-induced calcium sensitization by decreasing regulatory myosin light chain phosphorylation during receptor stimulation. Hexanol also inhibited increases in calcium sensitivity due to direct stimulation of heterotrimeric G-proteins with tetrafluoroaluminate but not with 3 μM GTPγS, consistent with prior results obtained with halothane. In contrast, in the absence of receptor stimulation, both compounds produced a small increase in calcium sensitivity by a G-protein - mediated increase in regulatory myosin light chain phosphorylation that was not affected by pertussis toxin treatment. Conclusions: The authors noted dual effects of hexanol and halothane. In the presence of muscarinic receptor stimulation, hexanol, like halothane, decreases calcium sensitivity by interfering with heterotrimeric G-protein function. However, in the absence of muscarinic receptor stimulation, hexanol and halothane slightly increase calcium sensitivity by a G-protein-mediated process not sensitive to pertussis toxin. Hexanol may represent a useful experimental tool to study the effect of anesthetics on heterotrimeric G-protein function.

AB - Background: Contraction of airway smooth muscle is regulated by receptor-coupled mechanisms that control the force developed for a given cytosolic calcium concentration (i.e., calcium sensitivity). Halothane antagonizes acetylcholine-induced increases in calcium sensitivity by inhibiting GTP-binding (G)-protein pathways. The authors tested the hypothesis that hexanol, like halothane, inhibits agonist-induced increases in calcium sensitivity in airway smooth muscle by inhibiting G-protein pathways. Methods: Calcium sensitivity was assessed using α-toxin-permeabilized canine tracheal smooth muscle. In selected experiments, regulatory myosin light chain phosphorylation was also determined by Western blotting in the presence and absence of 10 mM hexanol and/or 100 μM acetylcholine. Results: Hexanol (10 mM) and halothane (0.76 mM) attenuated acetylcholine-induced calcium sensitization by decreasing regulatory myosin light chain phosphorylation during receptor stimulation. Hexanol also inhibited increases in calcium sensitivity due to direct stimulation of heterotrimeric G-proteins with tetrafluoroaluminate but not with 3 μM GTPγS, consistent with prior results obtained with halothane. In contrast, in the absence of receptor stimulation, both compounds produced a small increase in calcium sensitivity by a G-protein - mediated increase in regulatory myosin light chain phosphorylation that was not affected by pertussis toxin treatment. Conclusions: The authors noted dual effects of hexanol and halothane. In the presence of muscarinic receptor stimulation, hexanol, like halothane, decreases calcium sensitivity by interfering with heterotrimeric G-protein function. However, in the absence of muscarinic receptor stimulation, hexanol and halothane slightly increase calcium sensitivity by a G-protein-mediated process not sensitive to pertussis toxin. Hexanol may represent a useful experimental tool to study the effect of anesthetics on heterotrimeric G-protein function.

UR - http://www.scopus.com/inward/record.url?scp=0345074174&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0345074174&partnerID=8YFLogxK

U2 - 10.1097/00000542-200304000-00013

DO - 10.1097/00000542-200304000-00013

M3 - Article

C2 - 12657848

AN - SCOPUS:0345074174

VL - 98

SP - 871

EP - 880

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 4

ER -